Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes

Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin

(2013) Lars P. Kristensen et al.   Journal of Proteomics

Estimating improvement in prediction with matched case–control designs

(2013) Aasthaa Bansal et al.   LIFETIME DATA ANALYSIS

Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis

(2013) Onno B. Bleijerveld et al.   Proteomics Clinical Applications

Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study

(2012) Jeffrey K. Lee et al.   PLoS One

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

(2011) Carlos O. Mendivil et al.   CIRCULATION

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial

(2011) H. M. Colhoun et al.   DIABETES

Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes

(2011) T. S. Ahluwalia et al.   DIABETOLOGIA

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

(2011) Andre Pascal Kengne et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review

(2011) S van Dieren et al.   HEART

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases

(2011) Allegra Battistoni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Plasma CD93 concentration is a potential novel biomarker for coronary artery disease

(2011) A. Mälarstig et al.   JOURNAL OF INTERNAL MEDICINE

Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia

(2010) Sandrine Caron et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice

(2010) Thomas van Es et al.   VACCINE

Local Atherosclerotic Plaques Are a Source of Prognostic Biomarkers for Adverse Cardiovascular Events

(2009) Dominique P.V. de Kleijn et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Influences of genetic variants in interleukin-15 gene and serum interleukin-15 levels on coronary heart disease

(2009) Cahide Gokkusu et al.   CYTOKINE

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

(2009) A. Hiukka et al.   DIABETES

Cross-sectional analysis of baseline data to identify the major determinants of carotid intima–media thickness in a European population: the IMPROVE study

(2009) Damiano Baldassarre et al.   EUROPEAN HEART JOURNAL

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study

(2008) P. G. Scheffer et al.   CLINICAL CHEMISTRY

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register

(2008) J. Cederholm et al.   DIABETES CARE

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

(2008) D. C. Chan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE